1. New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational prospective review
   Alok Raghav et al, 2022, Frontiers in Endocrinology CrossRef
2. GP-1447, an Inhibitor of Aldose Reductase, Prevents the Progression of Diabetic Cataract in Rats
   Ken Kawakubo et al, 2012, Biological and Pharmaceutical Bulletin CrossRef
3. The Pathophysiology of Cataract and Major Interventions to Retarding Its Progression: A Mini Review
   Andrews Nartey, 2017, Advances in Ophthalmology & Visual System CrossRef
4. Hyperglycemia Impairs Acetylcholine-Induced Vasodilation of Retinal Arterioles Through Polyol Pathway–Independent Mechanisms in Rats
   Asami Mori et al, 2010, Journal of Pharmacological Sciences CrossRef
5. Hiperglisemi, Oksidatif Stres ve Tip 2 Diyabette Oksidatif Stres Belirteçlerinin Tanımlanması
   Özlem ÇETİNER et al, 2020, Turkish Journal of Diabetes and Obesity CrossRef
6. A basic scientific understanding of diabetic retinopathy
   Nathaniel Sears et al, 2015, Managing Diabetic Eye Disease in Clinical Practice CrossRef
7. Promising Anti-stroke Signature of Voglibose: Investigation through In- Silico Molecular Docking and Virtual Screening in In-Vivo Animal Studies
   Pooja Shah et al, 2020, Current Gene Therapy CrossRef
8. Anticataractogenesis and Antiretinopathy Effects of the Novel Protective Agent Containing the Combined Extract of Mango and Vietnamese Coriander in STZ‐Diabetic Rats
   Jintanaporn Wattanathorn et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
9. Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy
   Trevor Askwith et al, 2009, American Journal of Physiology-Endocrinology and Metabolism CrossRef
10. Correction of pathological conditions associated with insulin-resistant hyperglycaemia
    E. Yu. Solovyeva et al, 2016, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova CrossRef
11. Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy in STZ-Diabetic RatsviaSuppression of Aldose Reductase, Oxidative Stress, and MAPK Signaling Pathway
    Fei Liu et al, 2020, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
12. A comprehensive study of therapeutic entities for treatment of cataract
    Kashish Mehla et al, 2023, THE FOURTH SCIENTIFIC CONFERENCE FOR ELECTRICAL ENGINEERING TECHNIQUES RESEARCH (EETR2022) CrossRef
13. Inhibitory effects ofSynurus excelsusandWeigela subsessilison aldose reductase and HPLC-UV analysis of scopolin, scopoletin, and quercetin
    Norman G. Quilantang et al, 2018, Journal of Applied Biological Chemistry CrossRef
14. Relationship between aldose reductase enzyme and the signaling pathway of protein kinase C in an in vitro diabetic retinopathy model
    Mutlu Sarikaya et al, 2020, Canadian Journal of Physiology and Pharmacology CrossRef
15. Pathophysiology of Diabetic Retinopathy
    Natalia Lobanovskaya, 2022, Diabetic Eye Disease - From Therapeutic Pipeline to the Real World CrossRef
16. Development of a Stability-indicating RP-UPLC Method for determination of Fidarestat in Bulk Drug
    Twinkle Sakariya et al, 2022, Research Journal of Pharmacy and Technology CrossRef